Drug-Resistant TB

Experts on Xpert: A Laboratorian and a Clinician Discuss Interpretation of Xpert MTB/RIF Results

Description: 

This 70-minute presentation (followed by a 20-minute Q & A session) will discuss the principles of Xpert MTB/RIF testing, highlighting it as an important tool for the rapid diagnosis of TB and how to best utilize the tool. A laboratorian and a clinician will review the rules set by the manufacturer, present cases that address pitfalls in interpretation of test results, and offer expert opinion on how to proceed.

1.50 CEU

1.50 CME

Basics of MDR-TB Clinical Care: Online Video Series

The Basics of MDR-TB Clinical Care: Online Video Series is comprised of a series of short, online lectures presented in easy to digest segments. The first three installments are now available and the complete series will cover major topics pertaining to epidemiology, diagnosis, treatment regimens, monitoring and case management, side-effects, prevention and isolation, treatment of contacts, and special situations. 

Drug-Resistant Tuberculosis: A Survival Guide for Clinicians, 3rd edition

First released in 2004, the Guide is a joint publication of CITC and the Tuberculosis Control Branch of the California Department of Public Health. It contains information and user-friendly tools and templates for use by any clinician who participates in the management of patients with drug-resistant TB. 
The 10 chapters and 4 appendices cover major topics pertaining to epidemiology, diagnosis, laboratory issues, treatment, medications, pediatrics, co-morbidities and special situations, monitoring and case management, adverse reactions, and treatment of contacts.

Tuberculosis Drug Information Guide, 2nd edition

The first edition (2009) of Tuberculosis Drug Information Guide was derived from Drug-Resistant Tuberculosis: A Survival Guide for Clinicians (2nd edition) produced in 2008 by the Curry International Tuberculosis Center (CITC) and the State of California Department of Public Health, Tuberculosis Control Branch (CDPH).

The information in Tuberculosis Drug Information Guide, 2nd edition was updated in December, 2012.